|Date Initiated by Firm
||January 28, 2013
|Date Posting Updated
||March 14, 2013
||Terminated 3 on July 19, 2013
|Recall Event ID
||Plasma, coagulation factor deficient - Product Code GJT
1) LIATEST VWF:Ag Buffer - 5 ml Diagnostica Stago
2) LIATEST VWF:Ag Latex + 4 ml R3 Diagnostica Stago
3) LIATEST VWF:Ag Latex Diluent 4 mL Diagnostica Stago
Model, catalogue, number 00518 - 58978 - 58979
DIAGNOSTICA STAGO S.A.S.
92600 Asni¿res sur Seine (France)
||Lot/Unit Numbers : Combination of All STA-R¿/ STA-R EVOLUTION¿ and lots of STA¿ - LIATEST¿ VWF: AG are involved.
, Lot Number Expiry date, 108128 2013-03, 108512 2013-04, 108778 2013-07, 109415 2013-10, 109591 2014-01.
| Diagnostica Stago, Inc.
5 Century Dr
Parsippany NJ 07054-4607
|For Additional Information Contact
|Diagnostica Stago has confirmed that sometimes the delta OD measured can be changed leading to a lowered percentage result.
|Software design (manufacturing process)
||Diagnostica Stago Inc. sent e-mail notifications on 1/28/2013 to all consignees (laboratory supervisor). The written field safety notice, entitled Important Field Safety Notice, with its response form was attached. The letter identified the affected product and gave a description of the defect. Customers were asked to confirm all the results obtained in the abnormal range by either of the two methods provided. Users are to complete and return the enclosed response form as soon as possible to the Stago Hotline via fax, 973-644-9348. Questions should be directed to the Stago Hotline at 800-725-0607.
|Quantity in Commerce
||Worldwide Distribution - USA and Canada.
|Total Product Life Cycle
TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
||510(K)s with Product Code = GJT and Original Applicant = AMERICAN BIOPRODUCTS CO.